Industry chief hopeful administration carves out generics from pharma tariffs

Tariffs that President Trump has repeatedly promised to levy on the pharmaceutical sector should exclude generic drugs, Association for Accessible Medicines President and CEO John Murphy tells Inside U.S. Trade , arguing that generic medicines are uniquely vulnerable to tariffs because of low profit margins and static government reimbursement rates. The Commerce Department last week opened a 21-day comment period for its investigation into the national security implications of pharmaceutical imports under Section 232 of the Trade Expansion Act of...